These manipulations include introducing familial Alzheimer's disease L166P PS1 mutation, structural change in the Pen2 N-terminus, expressing Aph1B or Aph1A isoform, or pharmacological treatment (fenofibrate, ibuprofen). The gene discussed is APH1B; the disease is familial Alzheimer disease.